Cannabimovone (CBM), a rare cannabinoid can sensitize cells to insulin
News from the Institute of Biomolecular Chemistry in Italy. In a study published in the journal Molecules, researchers found that cannabimovone (CBM), a rare cannabinoid, can sensitize cells to insulin. CBM thus joins CBD, THC, THCV, and THCA as a potentially promising avenue of research for diabetes prevention. What is diabetes? Diabetes is a disease …
Cannabimovone (CBM), a rare cannabinoid can sensitize cells to insulin Read More »
